What is a Biologic?


Activity Info

Upon completion of the activity, participants should be able to:
1. Answer patient questions about the differences between biologics and small-molecule drugs
2. Explain the FDA process for the evaluation of post approval changes for reference biologics, and how this relates to biosimilars

CME/CE credit is no longer available for this activity.


Webinar | Oncology | 0.25 - 15 mins | Dermatology | Gastroenterology | Hematology | Rheumatology | Nurse | Biosimilars | BiosimilarsCME.org | Online | Pharmacist |